Romuald Harwas

Romuald Harwas has a diverse work experience spanning various industries and roles. Most recently, they serve as a Company Director at WPD Pharmaceuticals Inc. since January 2022. Prior to this, they held the position of Chief Financial Officer at Pure Biologics S.A. from July 2019. Romuald was also a key staff member at Platinum Alfa - Investment Fund from December 2019. In addition, Romuald has experience as an Independent Financial Advisor at their own practice since 2011. Romuald also served as a Member of the Supervisory Board at Synaptise from January 2019 to January 2022. Previously, they held the role of Group CFO at Nestmedic S.A. from July 2017 to October 2018, and at Synektik S.A. from February 2014 to June 2017. Furthermore, Romuald held the position of CFO - member of the board at Blue Energy Sp. z o.o. from October 2011 to December 2013. Additionally, they served as the CEO of Kolprojekt Ltd. from June 2010 to December 2013. Lastly, Romuald started their career as a Management Accountant at Bradken from June 2007 to June 2010.

Romuald Harwas pursued their education in the field of management and accounting. Romuald began their learning journey in 1992 at Uniwersytet Ekonomiczny w Krakowie, where they completed a Master's degree in Management & Accounting in 1997. Later, from 2010 to 2014, they enrolled at The Chartered Institute of Management Accountants, focusing on management accounting and earning a CIMA degree.